Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

Simple item page
dc.contributor.authorKlein, Nicola P.
dc.contributor.authorStockwell, Melissa S.
dc.contributor.authorDemarco, Maria
dc.contributor.authorGaglani, Manjusha
dc.contributor.authorKharbanda, Anupam B.
dc.contributor.authorIrving, Stephanie A.
dc.contributor.authorRao, Suchitra
dc.contributor.authorGrannis, Shaun J.
dc.contributor.authorDascomb, Kristin
dc.contributor.authorMurthy, Kempapura
dc.contributor.authorRowley, Elizabeth A.
dc.contributor.authorDalton, Alexandra F.
dc.contributor.authorDeSilva, Malini B.
dc.contributor.authorDixon, Brian E.
dc.contributor.authorNatarajan, Karthik
dc.contributor.authorStenehjem, Edward
dc.contributor.authorNaleway, Allison L.
dc.contributor.authorLewis, Ned
dc.contributor.authorOng, Toan C.
dc.contributor.authorPatel, Palak
dc.contributor.authorKonatham, Deepika
dc.contributor.authorEmbi, Peter J.
dc.contributor.authorReese, Sarah E.
dc.contributor.authorHan, Jungmi
dc.contributor.authorGrisel, Nancy
dc.contributor.authorGoddard, Kristin
dc.contributor.authorBarron, Michelle A.
dc.contributor.authorDickerson, Monica
dc.contributor.authorLiao , I-Chia
dc.contributor.authorFadel, William F.
dc.contributor.authorYang, Duck-Hye
dc.contributor.authorArndorfer, Julie
dc.contributor.authorFireman, Bruce
dc.contributor.authorGriggs, Eric P.
dc.contributor.authorValvi, Nimish R.
dc.contributor.authorHallowell, Carly
dc.contributor.authorZerbo, Ousseny
dc.contributor.authorReynolds, Sue
dc.contributor.authorFerdinands, Jill
dc.contributor.authorWondimu, Mehiret H.
dc.contributor.authorWilliams, Jeremiah
dc.contributor.authorBozio, Catherine H.
dc.contributor.authorLink-Gelles, Ruth
dc.contributor.authorAzziz-Baumgartner, Eduardo
dc.contributor.authorSchrag, Stephanie J.
dc.contributor.authorThompson, Mark G.
dc.contributor.authorVerani, Jennifer R.
dc.contributor.departmentFamily Medicine, School of Medicine
dc.date.accessioned2024-06-20T19:36:16Z
dc.date.available2024-06-20T19:36:16Z
dc.date.issued2022-03-04
dc.eprint.versionFinal published version
dc.identifier.citationKlein, N. P. (2022). Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years—VISION Network, 10 States, April 2021–January 2022. MMWR. Morbidity and Mortality Weekly Report, 71. https://doi.org/10.15585/mmwr.mm7109e3
dc.identifier.urihttps://hdl.handle.net/1805/41678
dc.language.isoen_US
dc.publisherCenters for Disease Control and Prevention
dc.relation.isversionof10.15585/mmwr.mm7109e3
dc.relation.journalMMWR Recommendations and Reports
dc.rightsPublisher Policy
dc.sourcePublisher
dc.subjectBNT162b2 (Pfizer-BioNTech) vaccine
dc.subjectCOVID-19
dc.subjectvaccine effectiveness (VE)
dc.titleEffectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Klein2022Effectiveness-PubP.pdf
Size:
162.02 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles